Aptevo Therapeutics (APVO) Tax Rate (2015 - 2019)

Aptevo Therapeutics (APVO) posted Tax Rate of 8.27% for Q3 2019, up 150.96% sequentially from 16.22% in Q4 2017.

Aptevo Therapeutics (APVO) Tax Rate (2015 - 2019) Analysis & Trends

Aptevo Therapeutics has reported Tax Rate for 4 years, with the latest figure at 8.27% in Q3 2019.

Quarterly Tax Rate changed N/A year-over-year to 8.27% in Q3 2019, while the trailing twelve-month figure through Sep 2019 was 15.35% (changed N/A YoY) and the FY2017 annual result came in at 22.83%, up 873.0% from the prior year.
Tax Rate improved to 8.27% in Q3 2019 per APVO's latest filing, from 16.22% in the prior quarter.
Over five years, Tax Rate peaked at 127.67% in Q3 2017 and troughed at 16.22% in Q4 2017.
A 4-year average of 14.13% and a median of 4.95% in 2015 frame the typical range for Tax Rate.
The widest YoY moves for Tax Rate: up 10832 bps in 2017, down 2359 bps in 2017.
Over 4 years, Tax Rate stood at 3.3% in 2015, then soared by 124 bps to 7.37% in 2016, then slumped by 320 bps to 16.22% in 2017, then jumped by 151 bps to 8.27% in 2019.
According to Business Quant data, Tax Rate over the past three periods registered 8.27%, 16.22%, and 127.67% for Q3 2019, Q4 2017, and Q3 2017 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	15.11%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	10.91%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	34.12%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Aptevo Therapeutics	3.18 Mn	-6.61 Mn	-	-

Download Data